Top
US_Flag An official website of the United States government Here's how you know
GOV

The .gov means it's official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

LOCK

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

 
U.S. Food & Drug Administration
Continuing Education and Accreditation
Division of Learning and Organizational Development
Center for Drug Evaluation and Research

Notice of Reorganization

The FDA's accredited Continuing Education program has been impacted by the reorganization of HHS and FDA, which took effect April 1, 2025. There are currently no staff available to process applications or continuing education credit.

For any staff remaining with FDA, please reach out directly to your supervisor for guidance on any future training events/activities for professional development and continuing education credits. For members of the public, please see www.fda.gov for updates.

FDA Rare Disease Day 2024: Navigating Information. Empowering Patients and Providers

Enroll
Step Status
Educational Content ✘
Posttest ✘
Evaluation ✘
Starts On: Mon, 4/29/24: 12:00 AM EDT
Ends On: Wed, 4/28/27: 12:00 AM EDT
Type: Enduring Material
Credits: 2
Description: In this enduring material, FDA experts discuss how to find information related to FDA-approved drugs, information on clinical trials, and how to understand informed consent documents for clinical trials.
Objectives:
  • Identify where to find important information and documents related to clinical trials and medical products in the United States.
  • Define the types of information that can be obtained from medical product labels.
  • Explain, in general terms, the legal and ethical requirements for consent forms in clinical trials.
Additional Information: Review the Activity Announcement for additional details: Announcement Form